Janux Therapeutics Inc (JANX)
55.80
+1.41
(+2.59%)
USD |
NASDAQ |
Nov 04, 16:00
56.00
+0.20
(+0.36%)
After-Hours: 20:00
Janux Therapeutics Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2021
--
Maximum
Mar 2021
--
Average
--
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Dynavax Technologies Corp | 0.3473 |
| Krystal Biotech Inc | 0.00 |
| Arcus Biosciences Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 691.41M |
| Total Liabilities (Quarterly) | 33.74M |
| Shareholders Equity (Quarterly) | 657.68M |
| Current Ratio | 57.34 |